sodium thiosulfate has been researched along with Neuroblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harned, TM; Iovine, P; Ji, L; Kalous, O; Loera, J; Neuwelt, A; Neuwelt, EA; Reynolds, CP; Sposto, R | 1 |
| Coyle, JT; Fisher, A; Hanin, I; McKinney, M; Sandberg, K; Schnaar, RL | 1 |
2 other study(ies) available for sodium thiosulfate and Neuroblastoma
| Article | Year |
|---|---|
Sodium thiosulfate administered six hours after cisplatin does not compromise antineuroblastoma activity.
Topics: Animals; Antineoplastic Agents; Carboplatin; Cell Hypoxia; Cell Line, Tumor; Cisplatin; Humans; Mice; Mice, Nude; Neuroblastoma; Radiation-Sensitizing Agents; Thiosulfates; Xenograft Model Antitumor Assays | 2008 |
AF64A: an active site directed irreversible inhibitor of choline acetyltransferase.
Topics: Animals; Aziridines; Azirines; Cell Line; Choline; Choline Kinase; Choline O-Acetyltransferase; Cholinesterase Inhibitors; Glioma; Kinetics; Neuroblastoma; Thiosulfates | 1985 |